Cargando…
Case Report: Drug-Induced (Neuro) Sarcoidosis-Like Lesion Under IL4 Receptor Blockade With Dupilumab
Dupilumab is a new monoclonal antibody inhibiting IL-4 and IL-13 signaling transduction through the blockage of the α-subunit of the IL-4 receptor. It is used to treat type 2 inflammatory disorders including atopic dermatitis, asthma, and chronic rhinosinusitis. Here we describe the case of a 79-yea...
Autores principales: | Tsitos, Stergios, Niederauer, Lisa Catherina, Albert i Gracenea, Paula, Mueller, Johanna, Straube, Andreas, Von Baumgarten, Louisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252288/ https://www.ncbi.nlm.nih.gov/pubmed/35795795 http://dx.doi.org/10.3389/fneur.2022.881144 |
Ejemplares similares
-
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021) -
Neuro-Behçet With a Thalamic Lesion: A Case Report
por: Piña-Ballantyne, Steven-Andrés, et al.
Publicado: (2023) -
Case report: A case of neuro-Behçet's syndrome presenting as brain stem mass lesions
por: Ayoade, Folusakin, et al.
Publicado: (2023) -
Challenges in Neuro-Otology
por: Strupp, Michael
Publicado: (2010) -
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
por: Le Floc’h, Audrey, et al.
Publicado: (2020)